Mark Liebow

3.7k total citations
44 papers, 1.5k citations indexed

About

Mark Liebow is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Mark Liebow has authored 44 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Mark Liebow's work include Lymphoma Diagnosis and Treatment (10 papers), Healthcare cost, quality, practices (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Mark Liebow is often cited by papers focused on Lymphoma Diagnosis and Treatment (10 papers), Healthcare cost, quality, practices (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Mark Liebow collaborates with scholars based in United States, Belarus and Vietnam. Mark Liebow's co-authors include Zachary S. Fredericksen, James R. Cerhan, Susan L. Slager, Alice H. Wang, Thomas M. Habermann, Timothy G. Call, Julie M. Cunningham, Stephen M. Ansell, Gavin C. Harewood and Eric S. Edell and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Mark Liebow

44 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Liebow United States 23 300 260 229 225 218 44 1.5k
Emili Vela Spain 26 348 1.2× 320 1.2× 290 1.3× 134 0.6× 207 0.9× 115 2.4k
Usa Chaikledkaew Thailand 25 188 0.6× 154 0.6× 175 0.8× 160 0.7× 157 0.7× 134 1.8k
Aihua Bian United States 32 521 1.7× 287 1.1× 215 0.9× 100 0.4× 296 1.4× 86 2.8k
Robin Zoň United States 25 256 0.9× 149 0.6× 931 4.1× 136 0.6× 333 1.5× 71 2.1k
Paul Carter United Kingdom 22 275 0.9× 108 0.4× 473 2.1× 114 0.5× 163 0.7× 35 1.7k
Ned Calonge United States 20 211 0.7× 199 0.8× 484 2.1× 198 0.9× 269 1.2× 55 1.8k
Lauren P. Wallner United States 28 199 0.7× 300 1.2× 656 2.9× 102 0.5× 225 1.0× 130 2.0k
W. Marieke Schoonen United Kingdom 12 202 0.7× 64 0.2× 208 0.9× 190 0.8× 277 1.3× 18 2.2k
Elizabeth A. Middleton United States 23 398 1.3× 594 2.3× 295 1.3× 64 0.3× 150 0.7× 49 2.7k
Gregory S. Calip United States 24 248 0.8× 139 0.5× 632 2.8× 80 0.4× 445 2.0× 175 2.1k

Countries citing papers authored by Mark Liebow

Since Specialization
Citations

This map shows the geographic impact of Mark Liebow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Liebow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Liebow more than expected).

Fields of papers citing papers by Mark Liebow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Liebow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Liebow. The network helps show where Mark Liebow may publish in the future.

Co-authorship network of co-authors of Mark Liebow

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Liebow. A scholar is included among the top collaborators of Mark Liebow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Liebow. Mark Liebow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boyle, Terry, Geffen Kleinstern, Paige M. Bracci, et al.. (2022). Physical activity and the risk of non‐Hodgkin lymphoma subtypes: A pooled analysis. International Journal of Cancer. 152(3). 396–407. 3 indexed citations
2.
Liebow, Mark, Melissa C. Larson, Carrie A. Thompson, et al.. (2021). Aspirin and other nonsteroidal anti‐inflammatory drugs, statins and risk of non‐Hodgkin lymphoma. International Journal of Cancer. 149(3). 535–545. 7 indexed citations
3.
Warsame, Rahma, Sarah M. Jenkins, Kandace A. Lackore, et al.. (2020). Responsibilities, Strategies, and Practice Factors in Clinical Cost Conversations: a US Physician Survey. Journal of General Internal Medicine. 35(7). 1971–1978. 8 indexed citations
4.
Ganesh, Ravindra, et al.. (2020). Perioperative Evaluation and Management of Endocrine Disorders. Mayo Clinic Proceedings. 95(12). 2760–2774. 26 indexed citations
5.
Famà, Angelo, Melissa C. Larson, Brian K. Link, et al.. (2019). Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 71(5). 1221–1228. 22 indexed citations
6.
Kleinstern, Geffen, Matthew J. Maurer, Mark Liebow, et al.. (2018). History of autoimmune conditions and lymphoma prognosis. Blood Cancer Journal. 8(8). 73–73. 24 indexed citations
7.
Famà, Angelo, Jinhua Xiang, Brian K. Link, et al.. (2018). Human Pegivirus infection and lymphoma risk and prognosis: a North American study. British Journal of Haematology. 182(5). 644–653. 20 indexed citations
8.
Starr, Stephanie R., Neera Agrwal, Michael Bryan, et al.. (2017). Science of Health Care Delivery. SHILAP Revista de lepidopterología. 1(2). 117–129. 16 indexed citations
9.
Tilburt, Jon C., Matthew K. Wynia, Víctor M. Montori, et al.. (2014). Shared decision-making as a cost-containment strategy: US physician reactions from a cross-sectional survey. BMJ Open. 4(1). e004027–e004027. 11 indexed citations
10.
Antiel, Ryan M., Katherine M. James, Jason S. Egginton, et al.. (2013). Specialty, Political Affiliation, and Perceived Social Responsibility Are Associated with U.S. Physician Reactions to Health Care Reform Legislation. Journal of General Internal Medicine. 29(2). 399–403. 22 indexed citations
11.
Kelly, Jennifer L., Matthew T. Drake, Zachary S. Fredericksen, et al.. (2012). Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes & Control. 23(7). 1017–1029. 35 indexed citations
12.
Kelly, Jennifer L., Zachary S. Fredericksen, Mark Liebow, et al.. (2012). The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender. Annals of Epidemiology. 22(12). 855–862. 16 indexed citations
13.
Holtan, Shernan G., Helen M. O’Connor, Zachary S. Fredericksen, et al.. (2011). Food‐frequency questionnaire‐based estimates of total antioxidant capacity and risk of non‐Hodgkin lymphoma. International Journal of Cancer. 131(5). 1158–1168. 36 indexed citations
14.
Kelly, Jennifer L., Anne J. Novak, Zachary S. Fredericksen, et al.. (2010). Germline Variation in Apoptosis Pathway Genes and Risk of Non–Hodgkin's Lymphoma. Cancer Epidemiology Biomarkers & Prevention. 19(11). 2847–2858. 34 indexed citations
15.
Cerhan, James R., Anne J. Novak, Zachary S. Fredericksen, et al.. (2009). Risk of non‐Hodgkin lymphoma in association with germline variation in complement genes. British Journal of Haematology. 145(5). 614–623. 14 indexed citations
16.
Vierkant, Robert A., Catherine M. Phelan, Brooke L. Fridley, et al.. (2009). Polymorphisms in NF-κB Inhibitors and Risk of Epithelial Ovarian Cancer. BMC Cancer. 9(1). 170–170. 17 indexed citations
17.
Kelemen, Linda E., Thomas A. Sellers, Joellen M. Schildkraut, et al.. (2008). Genetic Variation in the One-Carbon Transfer Pathway and Ovarian Cancer Risk. Cancer Research. 68(7). 2498–2506. 50 indexed citations
18.
Slager, Susan L., Neil E. Kay, Zachary S. Fredericksen, et al.. (2007). Susceptibility genes and B‐chronic lymphocytic leukaemia. British Journal of Haematology. 139(5). 762–771. 21 indexed citations
19.
Harewood, Gavin C., Maurits J. Wiersema, Eric S. Edell, & Mark Liebow. (2002). Cost-Minimization Analysis of Alternative Diagnostic Approaches in a Modeled Patient With Non-Small Cell Lung Cancer and Subcarinal Lymphadenopathy. Mayo Clinic Proceedings. 77(2). 155–164. 63 indexed citations
20.
Rich, Eugene C., et al.. (2002). Medicare financing of graduate medical education. Journal of General Internal Medicine. 17(4). 283–292. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emili Vela Breakdown of academic impact, for papers by Usa Chaikledkaew Breakdown of academic impact, for papers by Aihua Bian Breakdown of academic impact, for papers by Robin Zoň Breakdown of academic impact, for papers by Paul Carter Breakdown of academic impact, for papers by Ned Calonge Breakdown of academic impact, for papers by Lauren P. Wallner Breakdown of academic impact, for papers by W. Marieke Schoonen Breakdown of academic impact, for papers by Elizabeth A. Middleton Breakdown of academic impact, for papers by Gregory S. Calip
Rankless by CCL
2026